Experimental pharmacokinetics of rsu-1069 and its analogues: High tumor/plasma ratios
- 31 July 1986
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 12 (7) , 1087-1090
- https://doi.org/10.1016/0360-3016(86)90232-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analoguesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Analogues of RSU-1069: Radiosensitization and toxicity in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069International Journal of Radiation Oncology*Biology*Physics, 1984
- Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivoBritish Journal of Cancer, 1984
- In vivo assessment of basic 2-nitroimidazole radiosensitizersBritish Journal of Cancer, 1982
- Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogsBritish Journal of Cancer, 1980
- Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumoursBritish Journal of Cancer, 1979